Insider Trading & Ownership of Keith S. Manchester

Location
New York, NY
Summary
The estimated net worth of Keith S. Manchester is at least $401,044,190 dollars as of 13 Feb 2026. Keith S. Manchester is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $400.87M. Keith S. Manchester is the Director of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $170K.
Signature
/s/ Keith Manchester
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Keith S. Manchester and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Keith S. Manchester has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $401,044,190.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Roivant Sciences Ltd. ($400,874,218).
  • Past-year value change for that position: -$98,028,232.

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Keith S. Manchester

ROIV Forms 3/4/5

Roivant Sciences Ltd.

Relationship
Director
Holdings value
$400,874,218
Past year net change
-$98,028,232
Change %
-20%
Report period
11 Feb 2026

Insider Transactions Reported by Keith S. Manchester:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .